Fisher Paykel Healthcare Stock Current Valuation
| FPH Stock | 34.39 0.87 2.60% |
Valuation analysis of Fisher Paykel Healthcare helps investors to measure Fisher Paykel's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Fisher Paykel's Cash is comparatively stable compared to the past year. Total Cash From Operating Activities is likely to gain to about 451.1 M in 2024, whereas Total Cashflows From Investing Activities is likely to drop (10.7 M) in 2024. Fundamental drivers impacting Fisher Paykel's valuation include:
Price Book 12.2984 | Enterprise Value 19.6 B | Enterprise Value Ebitda 58.9109 | Price Sales 11.5389 | Forward PE 61.7284 |
Undervalued
Today
Please note that Fisher Paykel's price fluctuation is very steady at this time. Calculation of the real value of Fisher Paykel Healthcare is based on 3 months time horizon. Increasing Fisher Paykel's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Fisher Paykel's intrinsic value may or may not be the same as its current market price of 34.39, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 34.39 | Real 36.68 | Hype 34.4 | Naive 34.99 |
The intrinsic value of Fisher Paykel's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Fisher Paykel's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Fisher Paykel Healthcare helps investors to forecast how Fisher stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Fisher Paykel more accurately as focusing exclusively on Fisher Paykel's fundamentals will not take into account other important factors: Fisher Paykel Healthcare Company Current Valuation Analysis
Fisher Paykel's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Fisher Paykel Current Valuation | 19.63 B |
Most of Fisher Paykel's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fisher Paykel Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Fisher Paykel Healthcare has a Current Valuation of 19.63 B. This is 36.64% higher than that of the Health Care Equipment & Supplies sector and 114.66% higher than that of the Health Care industry. The current valuation for all Australia stocks is 18.06% lower than that of the firm.
Fisher Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fisher Paykel's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Fisher Paykel could also be used in its relative valuation, which is a method of valuing Fisher Paykel by comparing valuation metrics of similar companies.Fisher Paykel is currently under evaluation in current valuation category among its peers.
Fisher Fundamentals
| Return On Equity | 0.0755 | ||||
| Return On Asset | 0.0985 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.21 % | ||||
| Current Valuation | 19.63 B | ||||
| Shares Outstanding | 583.98 M | ||||
| Shares Owned By Insiders | 8.17 % | ||||
| Shares Owned By Institutions | 39.50 % | ||||
| Price To Book | 12.30 X | ||||
| Price To Sales | 11.54 X | ||||
| Revenue | 1.74 B | ||||
| Gross Profit | 938.4 M | ||||
| EBITDA | 444.8 M | ||||
| Net Income | 132.6 M | ||||
| Total Debt | 189.1 M | ||||
| Book Value Per Share | 3.02 X | ||||
| Cash Flow From Operations | 429.6 M | ||||
| Earnings Per Share | 0.20 X | ||||
| Price To Earnings To Growth | 4.47 X | ||||
| Target Price | 35.37 | ||||
| Number Of Employees | 6.98 K | ||||
| Beta | 0.39 | ||||
| Market Capitalization | 20.11 B | ||||
| Total Asset | 2.28 B | ||||
| Retained Earnings | 1.09 B | ||||
| Working Capital | 319.9 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 2.28 B | ||||
| Last Dividend Paid | 0.42 |
About Fisher Paykel Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fisher Paykel Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fisher Paykel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fisher Paykel Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fisher Stock Analysis
When running Fisher Paykel's price analysis, check to measure Fisher Paykel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fisher Paykel is operating at the current time. Most of Fisher Paykel's value examination focuses on studying past and present price action to predict the probability of Fisher Paykel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fisher Paykel's price. Additionally, you may evaluate how the addition of Fisher Paykel to your portfolios can decrease your overall portfolio volatility.